PRTA FY 2018 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$955,000-96.5% YoY

Gross Profit

-$100M-10495.1% margin

Operating Income

-$159M-16634.0% margin

Net Income

-$156M-16297.9% margin

EPS (Diluted)

$-3.93

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$30M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$499M

Total Liabilities

$176M

Stockholders' Equity

$323M

Cash & Equivalents

$428M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$955,000	$28M	-96.5%
Gross Profit	-$100M	-$107M	+6.4%
Operating Income	-$159M	-$155M	-2.3%
Net Income	-$156M	-$153M	-1.6%